Abstract
The introduction of calcium antagonists has considerably extended the potential drug treatments of angina pectoris. Given on their own (Freedman et al. 1980; Hopf et al. 1982) or in combination with organic nitrates (Raizner et al. 1981) and/or β-adrenergic blockers (Lessem 1981) calcium antagonists may afford an impressive increase of exercise tolerance in many patients. This holds for patients with stable angina pectoris as well as for patients in whom anginal symptoms may be triggered and possibly intensified by additional coronary spasms (Freedman et al. 1980; Maseri et al. 1975, 1978; Parodi et al. 1981; Raizner et al. 1981; Schulz et al. 1981).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Freedman B, Richmond DR, Kelly DT (1980) Coronary spasm management with Verapamil (Isoptin ®). Med J Aus 2: 22–25
Hopf R, Becker H-J, Kober G, Dowinsky S, Kaltenbach M (1982) Therapie der Angina pectoris mit Calcium-Antagonisten. Herz 4: 221–234
Lessem J (1981) Combined administration of Verapamil and Beta-blockers in patients with Angina pectoris. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam-Oxford-Princeton, p 159–166
Maseri A, Mimmo R, Chierchia S, Marchesi C, Pesola A, L’Abbate A (1975) Coronary artery spasm as a cause of acute myocardial ischemia in man. Chest 68: 625–633
Maseri A, L’Abbate A, Marzilli M, Ballestra AM, Chierchia S, Parodi O, Severi S (1978) Coronary vasospasm as a cause of acute myocardial infarction: A conclusion suggested by the study of Preinfarction Angina. In: Kaltenbach M, Lichtlen P, Balcon R, Bussmann W-D (eds) Coronary heart disease, 3rd Int Symp Frankfurt Thieme, Stuttgart p 163–173
Parodi O, L’Abbate A, Simonetti I, Severi S, Marzullo P, Trivella MG, Maseri A (1981) Verapamil in the treatment of vasospastic Angina pectoris. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam Oxford Princeton, p 176–184
Raizner AE, Chahine RA, Gaston WR, Smith DL, Luchi RJ, Miller RR (1981) The effectiveness of combined Verapamil and Nitrate therapy in Prinzmetal’s Variant Angina. In: Zanchetti A, Krikler DM (eds) Calcium antagonism in cardiovascular therapy: Experience with Verapamil. Excerpta Medica, Amsterdam Oxford Princeton, p 191–197
Schulz W, Krauss G, Kaltenbach M, Kober G (1981) Einfluß von intrakoronarem und intravenösem Nifedipin auf die allgemeine und lokale Gefäßweite von epikardialen Koronararterien bei stabiler Angina pectoris — ein antianginöser Wirkaspekt? Z Kardiol 70: 809–815
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hopf, R., Drews, H., Kaltenbach, M. (1984). Anti-anginal Effect of Gallopamil as Compared with Nifedipine. In: Kaltenbach, M., Hopf, R. (eds) Gallopamil. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-07364-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-07364-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13737-5
Online ISBN: 978-3-662-07364-3
eBook Packages: Springer Book Archive